A Proof-of-Concept Electrochemical Skin Sensor for Simultaneous Measurement of Glial Fibrillary Acidic Protein (GFAP) and Interleukin-6 (IL-6) for Management of Traumatic Brain Injuries
Open Access
- 30 November 2022
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 12 (12) , 1095
Abstract
This work demonstrates the use of a noninvasive, sweat-based dual biomarker electrochemical sensor for continuous, prognostic monitoring of a Traumatic Brain Injury (TBI) with the aim of enhancing patient outcomes and reducing the time to treatment after injury. A multiplexed SWEATSENSER was used for noninvasive continuous monitoring of glial fibrillary acidic protein (GFAP) and Interleukin-6 (IL-6) in a human sweat analog and in human sweat. Electrochemical impedance spectroscopy (EIS) and chronoamperometry (CA) were used to measure the sensor response. The assay chemistry was characterized using Fourier Transform Infrared Spectroscopy (FTIR). The SWEATSENSER was able to detect GFAP and IL-6 in sweat over a dynamic range of 3 log orders for GFAP and 2 log orders for IL-6. The limit of detection (LOD) for GFAP detection in the sweat analog was estimated to be 14 pg/mL using EIS and the LOD for IL-6 was estimated to be 10 pg/mL using EIS. An interference study was performed where the specific signal was significantly higher than the non-specific signal. Finally, the SWEATSENSER was able to distinguish between GFAP and IL-6 in simulated conditions of a TBI in human sweat. This work demonstrates the first proof-of-feasibility of a multiplexed TBI marker combined with cytokine and inflammatory marker detection in passively expressed sweat in a wearable form-factor that can be utilized toward better management of TBIs. This is the first step toward demonstrating a noninvasive enabling technology that can enable baseline tracking of an inflammatory response.Keywords
This publication has 39 references indexed in Scilit:
- CMOS-compatible, label-free silicon-nanowire biosensors to detect cardiac troponin I for acute myocardial infarction diagnosisBiosensors and Bioelectronics, 2012
- Effect of the Modified Glasgow Coma Scale Score Criteria for Mild Traumatic Brain Injury on Mortality Prediction: Comparing Classic and Modified Glasgow Coma Scale Score Model Scores of 13Journal of Trauma: Injury, Infection & Critical Care, 2011
- Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum*Pediatric Critical Care Medicine, 2011
- Analytic Review: Interleukin-6 in Surgery, Trauma, and Critical Care: Part I: Basic ScienceJournal of Intensive Care Medicine, 2011
- Methods for the determination of limit of detection and limit of quantitation of the analytical methodsChronicles of Young Scientists, 2011
- Sterile Trauma to Normal Human Dermis Invariably Induces IL1beta, IL6 and IL8 in an Innate Response to “Danger”Acta Dermato-Venereologica, 2009
- Colocalization of Glial Fibrillary Acidic Protein, Metallothionein, and MHC II in Human, Rat, NOD/SCID, and Nude Mouse Skin Keratinocytes and FibroblastsJournal of Investigative Dermatology, 2007
- Increased serum-GFAP in patients with severe traumatic brain injury is related to outcomeJournal of the Neurological Sciences, 2006
- The Relationship of CSF and Plasma Cytokine Levels to Cerebral White Matter Injury in the Premature NewbornPediatric Research, 2005
- Biological and clinical aspects of interleukin 6Immunology Today, 1990